MiMedx Group, Inc. (MDXG) Gross Margin
- Gross margin · 12 months: Value 78.85%; Formula and calculation Gross profit / revenue. Period ending 2026-06-30..
Gross margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Gross margin · 12 months | 78.85% | Gross profit / revenue. Period ending 2026-06-30. $280.05M ÷ $355.17M × 100 ≈ 78.85% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Gross profit | 280.05M USD | Gross Profit |
| Revenue | 355.17M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | 75.12M USD | Cost of Goods and Services Sold |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Gross profit (USD) | Revenue (USD) | Cost of products and services (USD) | Gross margin |
|---|---|---|---|---|
| 2026-06-30 | $280.05M | $355.17M | $75.12M | 78.85% |
| 2026-03-31 | $315.59M | $389.42M | $73.82M | 81.04% |
| 2025-12-31 | $345.62M | $418.63M | $73.01M | 82.56% |
| 2025-09-30 | $322.57M | $393.44M | $70.87M | 81.99% |
| 2025-06-30 | $296.30M | $363.77M | $67.47M | 81.45% |
| 2025-03-31 | $288.73M | $352.38M | $63.64M | 81.94% |
| 2024-12-31 | $288.81M | $348.88M | $60.07M | 82.78% |
| 2024-09-30 | $285.80M | $342.80M | $57.01M | 83.37% |
| 2024-06-30 | $283.99M | $340.46M | $56.47M | 83.41% |
| 2024-03-31 | $279.31M | $334.51M | $55.20M | 83.50% |
| 2023-12-31 | $266.84M | $321.48M | $54.63M | 83.01% |
| 2023-09-30 | $253.86M | $309.02M | $55.16M | 82.15% |
| 2023-06-30 | $242.44M | $295.00M | $52.56M | 82.18% |
| 2023-03-31 | $229.82M | $280.62M | $50.80M | 81.90% |
| 2022-12-31 | $219.53M | $267.84M | $48.32M | 81.96% |
| 2022-09-30 | $216.18M | $260.88M | $44.70M | 82.87% |
| 2022-06-30 | $213.62M | $256.26M | $42.64M | 83.36% |
| 2022-03-31 | $213.96M | $257.54M | $43.58M | 83.08% |
| 2021-12-31 | $215.33M | $258.62M | $43.28M | 83.26% |
| 2021-09-30 | $216.41M | $259.75M | $43.35M | 83.31% |
| 2021-06-30 | $217.47M | $260.98M | $43.51M | 83.33% |
| 2021-03-31 | $207.52M | $246.47M | $38.95M | 84.20% |
| 2020-12-31 | $208.90M | $248.23M | $39.33M | 84.16% |
| 2020-09-30 | $214.86M | $256.09M | $41.22M | 83.90% |
| 2020-06-30 | $236.51M | $280.65M | $44.14M | 84.27% |
| 2020-03-31 | $248.75M | $294.44M | $45.69M | 84.48% |
| 2019-12-31 | $256.17M | $299.25M | $43.08M | 85.60% |
| 2019-09-30 | $274.67M | $315.44M | $40.77M | 87.07% |
| 2019-06-30 | $278.61M | $313.54M | $34.92M | 88.86% |
| 2019-03-31 | $307.07M | $341.52M | $34.45M | 89.91% |
| 2018-12-31 | $322.73M | $359.11M | $36.39M | 89.87% |
| 2018-09-30 | $319.00M | $354.38M | (m) | 90.02% |
| 2018-06-30 | $314.09M | $351.42M | (m) | 89.38% |
| 2018-03-31 | $299.94M | $336.49M | (m) | 89.14% |
| 2017-12-31 | $285.92M | $321.14M | $35.22M | 89.03% |
| 2017-09-30 | $267.43M | (m) | (m) | (m) |
| 2017-06-30 | $248.88M | (m) | (m) | (m) |
| 2017-03-31 | $231.05M | (m) | (m) | (m) |
| 2016-12-31 | $212.61M | (m) | (m) | (m) |
| 2016-09-30 | $198.65M | (m) | (m) | (m) |
| 2016-06-30 | $186.25M | (m) | (m) | (m) |
| 2016-03-31 | $176.90M | (m) | (m) | (m) |
| 2015-12-31 | $167.09M | (m) | (m) | (m) |
| 2015-09-30 | $156.22M | (m) | (m) | (m) |
| 2015-06-30 | $142.35M | (m) | (m) | (m) |
| 2015-03-31 | $124.59M | (m) | (m) | (m) |
| 2014-12-31 | $105.56M | (m) | (m) | (m) |
| 2014-09-30 | $84.47M | (m) | (m) | (m) |
| 2014-06-30 | $68.30M | (m) | (m) | (m) |
| 2014-03-31 | $56.78M | (m) | (m) | (m) |
| 2013-12-31 | $49.85M | (m) | (m) | (m) |
| 2013-09-30 | (m) | (m) | (m) | (m) |
| 2013-06-30 | (m) | (m) | (m) | (m) |
| 2013-03-31 | (m) | (m) | (m) | (m) |
| 2012-12-31 | $21.87M | (m) | (m) | (m) |
| 2012-09-30 | (m) | (m) | (m) | (m) |
| 2012-06-30 | (m) | (m) | (m) | (m) |
| 2012-03-31 | (m) | (m) | (m) | (m) |
| 2011-12-31 | (m) | $7.76M | (m) | (m) |
| 2011-09-30 | (m) | (m) | (m) | (m) |
| 2011-06-30 | (m) | (m) | (m) | (m) |
| 2011-03-31 | (m) | (m) | (m) | (m) |
| 2010-12-31 | (m) | $788.87K | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B |